Our webinars allow users to learn from experts and earn continuing education credits on industry topics, progress in research, services available, and more.
At Stago, we work with you to design a comprehensive hemostasis solution to fit the unique needs of your laboratory. Our unique approach focuses on improving patient outcomes and reducing the overall cost of care. Rest assured with reliable results from our standardized testing platforms. Expert support services combined with a complete menu of routine and specialty assays enable you to focus on your patients while we focus on you.
Routine coagulation assays are widely performed in laboratories and provide valuable information to the patient’s overall clinical picture. It’s important for laboratorians to kn...
Quality efforts in the clinical laboratory are always under the microscope- a hyper-focus for laboratorians from start to finish. Recognizing the external factors that affect hemostasis test...
Direct oral anticoagulants (DOACs), such as direct thrombin inhibitors and direct factor Xa inhibitors, are increasingly prescribed in various clinical scenarios for both adult and pediatric...
Clinical laboratories often interact their information technology (IT) department, especially when installing new instruments, adding new tests to the menu, defining critical values, analyzi...
Every area of the laboratory has specific issues with pre-analytical errors causing unreadable or false results on samples, from mislabeling to samples being forgotten on the floors to drawi...
Laboratories are required to participate in proficiency testing (PT). PT is a powerful tool for laboratories to learn about their own testing performance and discover potential issues with t...
Summary: Internal quality control is an integral process of laboratory testing. A clinical laboratory's coagulation quality control (QC) program is a critical component of its quality as...
In clinical laboratory settings, tests for coagulation factors are regularly run to test for inherited or acquired deficiencies in patients suspected of ongoing bleeding risk. Available test...
Heparin-Induced Thrombocytopenia (HIT): Practical Aspects of Clinical and Laboratory Diagnosis Heparin-Induced Thrombocytopenia (HIT) is a life-threatening complication following heparin exp...
Coagulation tests are useful in the diagnosis and management of bleeding or thrombotic disorders. The majority of hospital and reference laboratories perform routine coagulation testing such...
Heparin-Induced Thrombocytopenia (HIT) is a life-threatening complication following heparin exposure. This webinar presentation will discuss the pathogenesis, incidence, clinical...
The diagnosis of venous thromboembolism (VTE) is challenging during pregnancy. Pregnant women often present with symptoms compatible with VTE. The use of conventional diagnostic algorithms is...
Getting It Right: Preanalytical Impact on Coagulation Results Using a Case Study Approach According to published literature, up to 65% of errors occur in the preanalytical phase of laborator...
According to published literature, up to 65% of errors occur in the preanalytical phase of laboratory testing, and coagulation assays are particularly sensitive to preanalytical issues......
The Patient is Bleeding: Balancing Clinical and Laboratory Needs Coagulopathy in the bleeding surgical patient can get worse by the second! One of the real-world operational challenges......
Perhaps more than any other area of clinical medicine, anticoagulation management laboratory data are evaluated hourly by healthcare systems in the inpatient setting and daily in the outpatie...
The Patient with Venous Thrombosis - Practical Points for the Labor Diagnosis of deep vein thrombosis and pulmonary embolism, collectively referred to as...
Overview and learning objectives: Lupus anticoagulants are consistently present in patients at risk of thrombosis as a result of underlying antiphospholipid syndrome (aPS), a dangerous disor...
ASH Anticoagulation Guidelines in Patients with COVID-19: A moving target The American Society of Hematology (ASH) published in February 2021 “Anticoagulation Guidelines in Patients wi...
Date: September 16, 2020 Time: 7:00am (PDT), 10:00am (EDT) Of the 15 million patients admitted to US based hospitals with medical, non-surgical illnesses, 8 million possess inherent risk of...
This presentation will provide a discussion of the thromboembolism risk of COVID-19 and how this plays into laboratory medicine. This will include case based discussions on how different lab...
The International Council for Standardization in Haematology (ICSH) is a nonprofit organization dedicated to providing open-access guidance documents to enhance the quality of laboratory tes...
Rapid access to high quality comprehensive coagulation test results is critical to patient care. In an environment where clinical laboratories constantly experience price and labor pressure,...
This talk will cover different approaches to emergency hemostasis testing for patients that are actively bleeding due to trauma, surgery, obstetrical emergencies and other causes. The talk i...
The compendium of newly emerging and currently available hemophilia and anticoagulant treatments, while offering new choices for improved patient care, can create significant levels of inter...
Standardization and harmonization have come a long way in the last 3 to 4 decades; however, standardization is imperfect. Laboratory professional need to recognize the limitations of some of...
D-dimer is used in the clinical evaluation of suspected venous thromboembolism (VTE). Newer measurement methods show high sensitivity for this test, and in combination with pretest probabilit...
Learning objectives: Identify solutions in areas of coagulation that can be enhanced by implementing good laboratory practices and standard operating procedures Analyze re...
ABSTRACT Learning objectives: Highlight recent clinical trials describing use of DOACs Demonstrate if (ever) one needs to monitor DOACS Review best practice with respec...
Learning objectives: Describe the responsibility of the laboratory during the validation process of new instrumentation. Distinguish between validation and verification of laboratory...
The D-dimer can be a useful tool in the management of patients with suspected or established venous thromboembolism (VTE). One use is in the assessment of a patient who presents with symptoms...
DATE: August 8, 2018TIME: 8:00AM PT, 11:00AM ETAntiphospholipid syndrome (APS) is an autoimmune acquired thrombophilic disorder which is diagnosed based on clinical and labor...
Laboratory testing for coagulation factor deficiencies and inhibitors is very important for diagnosing and monitoring inherited and acquired coagulopathies and for evaluating the causes of co...
This session will look at the common issues that can impact quality in the coagulation laboratory and result outcomes. Implementing a good quality management system and being able to co...
Despite the development of new anticoagulants, unfractionated heparin (UFH) continues to be a primary intravenous anticoagulant therapy because of its titratability, short half-life, ability...
When patients taking direct oral anticoagulants (DOAC's) are admitted to the hospital, there may be a need for bridging parental anticoagulation especially for those at high risk of throm...
This webinar will look at the principles of the assays available to monitor heparin. The most frequent assay that is used is the activated partial thromboplastin time (aPTT). This...
Lupus anticoagulants are markers of prothrombotic potential which may be indicative of underlying antiphospholipid syndrome (aPS) requiring treatment with ongoing anticoagulants. The pu...
Routine coagulation assays are widely performed in laboratories and provide valuable information to the patient’s overall clinical picture. It’s important for laboratorians to kn...
